In 2023, the antiinfective medicine sales in the UK stood at 13.6% of total sales. Forecasted data for subsequent years are as follows: in 2024, 13.7%; in 2025, 13.8%; in 2026, 13.9%; in 2027, 14%; and in 2028, 14.1%. This indicates a steady year-on-year increase of approximately 0.1 percentage points.
Over the last two years (2023-2024), the variation was +0.1 percentage points. Over the five years from 2024 to 2028, we observe a consistent growth trend with a Compound Annual Growth Rate (CAGR) of approximately 0.36% per year.
Future trends to watch for include advancements in biotechnology and drug delivery systems, potential regulatory changes influencing market dynamics, and the impact of emerging pathogens that could reshape the demand for antiinfective medicines.
